Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Additions to SISCAPA Assay Technologies and More

Premium

SISCAPA Assay Technologies this week appointed Gustavo Salem to its board of directors and hired Ian Wright as a consultant and primary architect of diagnostic business strategy.

Salem was previously vice president and general manager of LC/MS at Agilent Technologies. Before that he was president and CEO of Assay Designs. He was also division manager of the Protein Separations Division at Bio-Rad.

Wright was previously head of the Strategic Innovation group and head of Global Assay Development at Siemens Healthcare Diagnostics.


Predictive Biosciences has named Pierre Cassigneul to be its new CEO, replacing Marc Schneebaum, who will return to his post as COO.

Cassigneul formerly was president, CEO, and vice chairman of the board at XDx, and he previously held management roles at Abbott Laboratories, Becton Dickinson, Bayer Diagnostics, and Ortho Diagnostic Systems. He also has served on the board of the Personalized Medicine Coalition.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.